Stay updated on AT2220 Safety Study in Pompe Disease Clinical Trial
Sign up to get notified when there's something new on the AT2220 Safety Study in Pompe Disease Clinical Trial page.

Latest updates to the AT2220 Safety Study in Pompe Disease Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedMajor update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.SummaryDifference4%

- Check29 days agoChange DetectedUpdated canonical name to Glycogen storage disease II and bumped revision to v3.1.0, replacing the prior Glycogen storage disease ii and v3.0.2.SummaryDifference0.2%

- Check43 days agoChange DetectedThe page metadata has been updated to version v3.0.2 with new date stamps (2025-09-11, 2025-09-09, 2025-09) and an 'Estimated' last update label, replacing older v3.0.1 metadata from 2018. No substantive changes to core content (pricing, stock, or time slots) were detected.SummaryDifference1%

- Check51 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.3%

- Check58 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, while removing specific details about previous location terms and certain medical classifications related to glycogen storage disease.SummaryDifference3%

- Check72 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%

Stay in the know with updates to AT2220 Safety Study in Pompe Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AT2220 Safety Study in Pompe Disease Clinical Trial page.